Not Yet Recruiting
Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma
NCT07131345
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
Not specified